|
180 Life Sciences Corp. (ATNF) DCF Valuation
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
180 Life Sciences Corp. (ATNF) Bundle
Simplify 180 Life Sciences Corp. (ATNF) valuation with this customizable DCF Calculator! Featuring real 180 Life Sciences Corp. (ATNF) financials and adjustable forecast inputs, you can test scenarios and uncover 180 Life Sciences Corp. (ATNF) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -20.8 | -5.5 | -20.0 | -17.8 | -22.1 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .1 | .1 | .1 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -20.9 | -5.6 | -20.2 | -17.9 | -22.2 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | .1 | 2.1 | 8.2 | 7.0 | 2.0 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .3 | 1.1 | 2.2 | -.6 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | 4.1 | 8.5 | .6 | 1.8 | 2.2 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 |
| EBITAT | -20.9 | -6.2 | -20.1 | -17.5 | -19.9 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -17.1 | -2.5 | -29.1 | -13.3 | -20.1 | -2.2 | .0 | .0 | .0 | .0 |
| WACC, % | 4.96 | 4.96 | 4.96 | 4.9 | 4.69 | 4.89 | 4.89 | 4.89 | 4.89 | 4.89 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | -1 | |||||||||
| Equity Value | -1 | |||||||||
| Diluted Shares Outstanding, MM | 0 | |||||||||
| Equity Value Per Share | -3.00 |
What You Will Get
- Real ATNF Financial Data: Pre-filled with 180 Life Sciences Corp.'s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See 180 Life Sciences Corp.'s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Research Parameters: Adjust essential inputs such as market growth rates, clinical trial phases, and R&D expenditures.
- Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and additional financial metrics.
- High-Precision Accuracy: Incorporates 180 Life Sciences Corp.'s (ATNF) actual financial data for credible valuation results.
- Simplified Scenario Analysis: Easily explore various assumptions and assess their impacts on outcomes.
- Efficiency Booster: Streamlines the valuation process, removing the necessity for intricate model development from the ground up.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered 180 Life Sciences Corp. (ATNF) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for 180 Life Sciences Corp. (ATNF)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose 180 Life Sciences Corp. (ATNF) Calculator?
- Accuracy: Leverages real financial data from 180 Life Sciences Corp. for precise calculations.
- Flexibility: Tailored for users to easily adjust and experiment with various inputs.
- Time-Saving: Eliminate the complexities of creating a financial model from the ground up.
- Professional-Grade: Crafted with the expertise and precision expected by industry leaders.
- User-Friendly: Intuitive interface suitable for users of all financial backgrounds.
Who Should Use This Product?
- Healthcare Professionals: Understand advanced treatment methodologies and apply them using real-world case studies.
- Researchers: Integrate innovative approaches into studies or clinical trials.
- Investors: Evaluate your investment strategies and analyze valuation projections for 180 Life Sciences Corp. (ATNF).
- Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms.
- Entrepreneurs: Discover how biotech companies like 180 Life Sciences Corp. (ATNF) are assessed in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled 180 Life Sciences Corp. (ATNF) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for 180 Life Sciences Corp. (ATNF).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.